European Union (EU) competition to preempt vaccines. 강남풀살롱 Cuba's Communist Party newspaper Granma recently reported on the 12th (local time) that the second Corona 19 vaccine candidate, "Soberana (Public Rights)" developed under the leadership of the country's Finlai Vaccine Institute, has begun clinical trials. The vaccine candidate material is an innovative material that chemically 어게인셔츠룸 combines deactivated toxins with virus antigens and human cells, according to the media.
"The clinical trial of 'Soberana 1', which started in August, is going on without any major side effects, and we will release the test results soon," said Vincente Bencomo, director of the Finlai Vaccine Institute. The research team also plans to start clinical trials on two new 퍼펙트가라오케 candidate materials by the end of the year